Comparison between Avience Biomedicals IPO and Dasra Healthcare IPO.
Avience Biomedicals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Dasra Healthcare IPO is a SME Bookbuilding proposed to list at NSE SME.
| Avience Biomedicals IPO | Dasra Healthcare IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Fintellectual Corporate Advisors Pvt.Ltd. | Mark Corporate Advisors Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Asnani Stock Broker Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Avience Biomedicals IPO is up to ₹28.53 Cr whereas the issue size of the Dasra Healthcare IPO is up to ₹0.00 Cr. The final issue price of Avience Biomedicals IPO is ₹208.00 per share and of Dasra Healthcare IPO is .
| Avience Biomedicals IPO | Dasra Healthcare IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹196.00 per share | |
| Issue Price (Upper) | ₹208.00 per share | |
| Issue Price (Final) | ₹208.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 600 shares | |
| Fresh Issue Size | 13,71,600 shares | 37,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹28.53 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 13,71,600 shares | 37,50,000 shares |
| Issue Size Total (Amount) | up to ₹28.53 Cr | up to ₹0.00 Cr |
Avience Biomedicals IPO opens on Jun 18, 2026, while Dasra Healthcare IPO opens on . The closing date of Avience Biomedicals IPO and Dasra Healthcare IPO is Jun 22, 2026, and , respectively.
| Avience Biomedicals IPO | Dasra Healthcare IPO | |
|---|---|---|
| Anchor Bid Date | Jun 17, 2026 | |
| Issue Open | Jun 18, 2026 | |
| Issue Close | Jun 22, 2026 | |
| Basis Of Allotment (Tentative) | Jun 23, 2026 | |
| Initiation of Refunds (Tentative) | Jun 24, 2026 | |
| Credit of Share (Tentative) | Jun 24, 2026 | |
| Listing date (Tentative) | Jun 25, 2026 | |
| Anchor Lockin End date 1 | Jul 23, 2026 | |
| Anchor Lockin End date 2 | Sep 21, 2026 |
Avience Biomedicals IPO P/E ratio is 11.59, as compared to Dasra Healthcare IPO P/E ratio of .
| Avience Biomedicals IPO | Dasra Healthcare IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 87.89% | 100% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 64.59% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.59 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹114.09 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 50.14 | 7.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.84 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.97 | 1.42 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹17.94 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 49.89 | 30.79 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Avience Biomedicals IPO Retail Individual Investors (RII) are offered 4,81,200 shares while in Dasra Healthcare IPO retail investors are offered 4,81,200 shares. Qualified Institutional Buyers (QIB) are offered 2,73,600 shares in Avience Biomedicals IPO and 0 shares in Dasra Healthcare IPO.
| Avience Biomedicals IPO | Dasra Healthcare IPO | |
|---|---|---|
| Anchor Investor Reservation | 4,09,800 shares | 0 shares |
| Market Maker Reservation | 82,200 shares | 0 shares |
| QIB | 2,73,600 shares | 0 shares |
| NII | 2,07,000 shares | 0 shares |
| RII | 4,81,200 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 13,71,600 shares | 0 shares |
Avience Biomedicals IPO subscribed 270.19x in total, whereas Dasra Healthcare IPO subscribed .
| Avience Biomedicals IPO | Dasra Healthcare IPO | |
|---|---|---|
| QIB (times) | 196.77x | |
| NII (times) | 597.23x | |
| Big NII (times) | 670.18x | |
| Small NII (times) | 451.35x | |
| RII (times) | 401.36x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 270.19x |
